Quarterly Results

IOL CHEMICALS AND PHARMACEUTICALS LTD.

NSE : IOLCPBSE : 524164ISIN CODE : INE485C01011Industry : Pharmaceuticals & DrugsHouse : Trident
BSE384.60-4.6 (-1.18 %)
PREV CLOSE ( ) 389.20
OPEN PRICE ( ) 385.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 19859
TODAY'S LOW / HIGH ( )380.20 389.05
52 WK LOW / HIGH ( )350.3 535.6
NSE385.05-4 (-1.03 %)
PREV CLOSE( ) 389.05
OPEN PRICE ( ) 384.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 385.05 (797)
VOLUME 150400
TODAY'S LOW / HIGH( ) 380.10 388.85
52 WK LOW / HIGH ( )350.55 535.9
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
5203.9
5453
5631.8
5872.1
Total Expenditure
4760.4
4811
4906.6
4919.1
PBIDT (Excl OI)
443.5
642
725.2
953
Other Income
83.8
71.1
70.6
87.3
Operating Profit
527.3
713.1
795.8
1040.3
Interest
43
44.4
39.5
48.8
Exceptional Items
NA
NA
NA
NA
PBDT
484.3
668.7
756.3
991.5
Depreciation
163.4
156.9
144.5
121.1
Profit Before Tax
320.9
511.8
611.8
870.4
Tax
90.1
133.1
153.2
222.6
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
230.8
378.7
458.6
647.8
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
230.8
378.7
458.6
647.8
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
230.8
378.7
458.6
647.8
Equity Capital
587.1
587.1
587.1
587.1
Face Value (IN RS)
10
10
10
10
Reserves
15542.2
15310.3
14936.4
14490.1
Calculated EPS
3.93
6.45
7.81
11.03
Calculated EPS (Annualised)
15.72
25.80
31.24
44.13
No of Public Share Holdings
30415425
30415425
30415425
30415425
% of Public Share Holdings
51.81
51.81
51.81
51.81
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
8.52
11.77
12.87
16.22
PBIDTM%
10.13
13.07
14.13
17.71
PBDTM%
9.30
12.26
13.42
16.88
PBTM%
6.16
9.38
10.86
14.82
PATM%
4.43
6.94
8.14
11.03
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.